French biotech snags vaccine grant; Novavax rises on early RSV data;

> French biotech Imaxio and its partners have won a grant to develop a Staphylococcus aureus vaccine. Release (pdf)

> Positive results from an early-phase respiratory virus vaccine trial pushed Novavax ($NVAX) shares higher. News

> Indian firm Biological E has won a $200 million deal to supply pentavalent vaccines to Egypt. Article

> A genital herpes vaccine is advancing toward clinical trials. Piece

> Indian regulators continue to investigate the relabeling of vaccines by Panacea Biotec. Item

> A malaria vaccine is tipped to enter clinical trials after impressing in mice. Study

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.